Enwei Pharmaceuticals: Vice President Plans to Reduce Stake by 0.0158%

Enwei Pharmaceuticals announced that the company's vice president, Chen Lei, holds 65,118 shares, accounting for 0.0633% of the total share capital of the company, and 0.0644% of the total share capital after excluding repurchased shares. He plans to reduce his holdings by no more than 16,279 shares through centralized bidding within three months after the date of the disclosure of the reduction plan, accounting for 0.0158% of the total share capital of the company, and 0.0161% of the total share capital after excluding repurchased shares. The source of the shares to be sold is from equity incentive shares, and the selling price will be determined based on the market price at the time of implementation.